EcoR1 Capital’s Contineum Therapeutics CTNM Stock Holding History
Bought
Maintained
Sold
Other funds holding CTNM
EcoR1 Capital's CTNM Position: Q3 2026 in Review
EcoR1 Capital opened a new position in Contineum Therapeutics (CTNM) in Q3 2026: 64,303 shares worth $863K. The stake represents 0.04% of the portfolio and ranks #35 among its holdings.
115 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.
- EcoR1 Capital held 64,303 shares of Contineum Therapeutics worth $863K as of Q3 2026.
- Contineum Therapeutics was a new EcoR1 Capital position in Q3 2026.
- Contineum Therapeutics made up 0.04% of EcoR1 Capital's portfolio in Q3 2026, its #35 holding.
- 115 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.
Based on EcoR1 Capital's 13F filing for Q3 2026, filed 16 Nov 2026.